Capricor's Reverse Merger Round

Capricor raised a round of funding on July 08, 2013. Investors include Nile Therapeutics.

Capricor is a privately held biotechnology company that aims to create powerful, yet easy-to-administer cardiac stem cell treatments to regenerate damaged heart muscle and improve heart function for p…

Articles about Capricor's Reverse Merger Round: